Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.
NCT ID: NCT01250184
Last Updated: 2014-10-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
127 participants
INTERVENTIONAL
2009-05-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: Single-blind, randomized, controlled clinical trial with three parallel groups in the departments of physical medicine and rehabilitation of two urban hospitals. There were 127 patients with myofascial pain in the shoulder girdle for more than six weeks in length and pain greater than 40 mm on the visual analog scale (VAS). There were three intervention groups: physical therapy (PT), lidocaine injection (LI), or the combination of both (PT + LI). The primary outcome at one month was the VAS, and the secondary outcomes were measured using the SF36 pain scaleat one and three months.
Keywords: Myofascial pain, trigger points, lidocaine injection, physical therapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intratissue Percutaneous Electrolysis vs Dry Needling in Myofascial Pain Syndrome of Shoulder Pain
NCT05593848
Immediate Stiffness Changes in Myofascial Trigger Points After Dry Needling
NCT04832074
Dry Needling Versus Intramuscular Stimulation in the Management of the Myofascial Trigger Points
NCT03025230
Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients
NCT01520415
Extracorporeal Shockwave Therapy vs Mesotherapy in the Treatment of Myofascial Pain Syndrome: a Case-control Study
NCT06246591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The physical and rehabilitation doctors who evaluated the patients and the nurse who assessed the patients were blinded to treatment allocation. Physicians who performed the MTP injection did not participate in the evaluation of primary and secondary outcomes. Physical therapists who conducted the therapeutic exercise program did not participate in the evaluation of primary and secondary outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physical Therapy
Twelve sessions, 3 per week.
Physical therapy
Twelve sessions (3 per week)
Lidocaine injection
Blocking the myofascial trigger point (MTP) with lidocaine injection, unique dose.
Lidocaine injection
blocking the Myofascial trigger point (MTP) with lidocaine injection, unique dose.
Lidocaine injection + physical therapy
Blocking the Myofascial trigger point (MTP) with lidocaine injection plus a standarized therapeutic exercise program, twelve sessions, 3 per week.
Lidocaine injection + physical therapy
blocking the Myofascial trigger point (MTP) with lidocaine injection plus a standarized therapeutic exercise program (twelve sessions, 3 per week)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical therapy
Twelve sessions (3 per week)
Lidocaine injection
blocking the Myofascial trigger point (MTP) with lidocaine injection, unique dose.
Lidocaine injection + physical therapy
blocking the Myofascial trigger point (MTP) with lidocaine injection plus a standarized therapeutic exercise program (twelve sessions, 3 per week)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 40 mm in the VAS
* They cannot been received treatment like physical therapy or analgesics
* Maximum score of PHQ 16 points
Exclusion Criteria
* Fibromyalgia
* Cervical Radiculopathy
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Antioquia
OTHER
Grupo Rehabilitacion en Salud
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luz Helena Lugo Agudelo
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luz H Lugo Agudelo, Professor
Role: PRINCIPAL_INVESTIGATOR
Universidad de Antioquia Grupo Rehabilitacion en Salud
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica de Las Américas
Medellín, Antioquia, Colombia
Ips Universitaria
Medellín, Antioquia, Colombia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GrupoRS0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.